The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy.
Yanzhao ZhouJingzhong OuyangHongcai YangZhengzheng WangFeng YeQingjun LiHaitao ZhaoJinxue ZhouQiang LiPublished in: Journal of hepatocellular carcinoma (2024)
This study first demonstrated that high VATI and mid-level BMI were protective for the survival of patients with HCC receiving immunotherapy. Skeletal muscle status (including SMI and SMD) may be the better predictor for outcomes of patients with HCC receiving immunotherapy.